EFDID: 373515EFD: View Filing

Issuer: Ashvattha Therapeutics, Inc. (0001668528) - D

Accession: 0001104659-21-060161 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001668528
  • Entity Name:
    Ashvattha Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    CALIFORNIA
  • Year of Inc:
    Over 5 years ago
  • Address:
    1235 RADIO ROAD, SUITE 200
    REDWOOD CITY, CA 94065
  • Persons:
    Related Persons 6
    Jeffrey Cleland
    Executive Officer, Director
    Sujatha Kannan
    Director
    Kannan Rangaramanujam
    Executive Officer, Director
    Barbara Slusher
    Director
    Jay Zaveri
    Director
    George Montgomery
    Director
EDGAR: Offering Information
  • Accession Date:
    05/03/2021
  • First Sale Date:
    04/16/2021
  • Offering Amount:
    $9,564,619
  • Amount Sold:
    $7,725,000
  • Amount Remaining:
    $1,839,619
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Convertible notes and warrants
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:AL, CA, CT, IN, MA, MI, NC, NJ, TX
Inactive:CO, IL, NY, VT
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
GP Nurmenkari Inc. 153480 None None AL, CA, CO, CT, FL, IL, IN, MA, MI, NJ, NY, NC, TX, VT
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Ashvattha Therapeutics, Inc./s/ Jeffrey ClelandJeffrey ClelandPresident2021-04-29
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Dec. 30, 2022 373515: 0001104659-22-131412 Ashvattha Therapeutics, Inc.
Amount Sold: $60,181,969
D May. 03, 2021 373515: 0001104659-21-060161 Ashvattha Therapeutics, Inc.
Offer Amount: $9,564,619
Amount Sold: $7,725,000
Remaining: $1,839,619